ELIXIR PHARMACEUTICALS

Details for Australian Trade Mark No. 961798 (hide)

Owner Elixir Pharmaceuticals, Inc. a Delaware corporation

Service Davies Collison Cave

Various Convention priority claimed: 15 January 2003, United States of America, No. 78/203617 and No. 78/203638.*

Classes

Class 5 Pharmaceutical preparations including pharmaceutical preparations in the fields of human genetics, genomics, aging and life span extension, and reduction of disease

Class 42 Product research and development services and commercialization in the fields of pharmaceuticals, human genetics, genomics, aging and life span extension, and reduction of disease

Event Publications

7 April 2005 Application Lapsed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

961800-E ELIXIR PHARMACEUTICALS

961794